Sign in
4

Changes in Ownership

Kura Oncology, Inc. Filed Acc 0001193125-26-464166

President and CEO bought 200,000 shares at an average $7.52 ($1,504,765)

From the SEC's structured data for this filing

Trades in this filing

WILSON TROY EDWARD · President and CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-11-13 Purchase : show line 1 in the form +98,881 $7.63 $754,462 534,337 D
2026-11-16 Purchase : show line 2 in the form +101,119 $7.42 $750,303 635,456 D
Open-market purchases · 200,000 sh · avg $7.52 · $1,504,765
Loading xslF345X06/ownership.xml…